Case Report: Post-CAR-T Infusion HBV Reactivation in Two Lymphoma Patients Despite Entecavir Preventive Therapy

Case Report: Post-CAR-T Infusion HBV Reactivation in Two Lymphoma Patients Despite Entecavir Preventive Therapy

Hepatitis B virus (HBV) reactivation is a common complication in chronic or resolved HBV infection patients undergoing immunosuppressive chemotherapy. Furthermore, few articles have been published regarding the risk of HBV reactivation in lymphoma patients receiving chimeric antigen receptor (CAR) T...

Full description

Bibliographic Details
Main Authors: Yaxian Ma, Li Yang, Yuhan Bao, Yang Yang, Liting Chen, Miao Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Immunology
Subjects:
hepatitis B virus
reactivation
CAR T
lymphoma
antiviral therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.751754/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.751754/full

Similar Items